canada semaglutide patent Aspen Pharmacare wins approval for generic Ozempic after Novo expiry Massive Rs 50,000 Cr Opportunity

Wegovy is now available as a daily pill (approved January 2026), and orforglipron (Foundayo by Eli Lilly) is an emerging oral small-molecule GLP-1 option

But their off-label use is for weight loss

Companies like Natco and Eris have introduced more affordable vial options, priced as low as 1,290 for a month's supply.

The cardiovascular benefits

Start your intake Current GLP-1 Adoption Rates and User Demographics Recent prescription tracking data indicates that GLP-1 medications have transitioned from niche diabetes treatments to mainstream weight management tools used by over 20 million people globally

Patients visit the official MEDVi website to complete a short medical questionnaire, after which a telehealth appointment is scheduled with a licensed doctor